A case study describes a rare but life-threatening complication linked to weight loss medications. Full details are in the NewsNation report.
Recap by typeshit. Full story at NewsNation.
European regulators first raised NAION, a rare optic nerve condition sometimes called an eye stroke, as a possible risk more than 15 months ago.
Obesity doctor Spencer Nadolsky takes on six popular misconceptions about Ozempic in a quick social video. The caption doesn't say which myths are covered.
Users described more appetite, fatigue, extra energy and insomnia. An analysis of Reddit comments, not a clinical trial, so the findings come from self-reports.
A piece on questions about tirzepatide and breast cancer risk. Only the headline is available, so check the source for what the evidence says.
Gizmodo covers a possible link between Ozempic and slower aging. The study itself and what it measured aren't described in the material given.
Oral versions of drugs like Wegovy and Mounjaro are expected to win TGA approval soon, following the US and Europe, AFR reports.
Loading…